Stay ahead with the latest Literature Screening webinar! Learn about AI automation and more…

Join us for a focused and dynamic 30-minute session where our expert dives into the latest advancements in pharmacovigilance literature screening. Gain actionable insights on overcoming industry challenges, leveraging AI and automation, and understanding emerging trends shaping the future of pharmacovigilance. The session will conclude with a Q&A to address your specific questions. On The […]

Join Qinecsa at DIA 2025 Pharmacovigilance & Risk Management Strategies Conference

Qinecsa is thrilled to be exhibiting at the DIA Global Pharmacovigilance & Risk Management Strategies Conference, from January 27-29 2025 in Baltimore, MD. DIA’s Global Pharmacovigilance and Risk Management Strategies Conference is a neutral event developed by regulators and industry experts discussing the updates, opportunities, and challenges alongside fresh problem-solving strategies that matter most to safety […]

Qinecsa President Featured in DIA Global Forum Issue

We are proud to announce that Humaira Qureshi, President of Qinecsa Solutions, has been featured in the September 2024 issue of the DIA Global Forum. In her article, titled “A New Pharmacovigilance Ecosystem: Automation, AI, and Continuous Improvement,” Humaira explores the evolution of pharmacovigilance (PV) as it transforms from a reactive, safety-focused function into a […]

Qinecsa Announces World Drug Safety Congress Americas Sponsorship

We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress America 2024! THE LARGEST DRUG SAFETY EVENT IN THE WORLD The World Drug Safety Congress Americas convenes top executives and key stakeholders in the biopharmaceutical sector to address critical issues in drug safety, pharmacovigilance, and medical device safety. Our team […]

What is Pharmacovigilance?

Pharmacovigilance is a critical component of the medicinal product lifecycle, focusing on ensuring the safety and efficacy of medicinal products from pre-clinical development through post-marketing surveillance. The primary goals of pharmacovigilance are to enhance patient safety, manage risks, and strengthen public health and trust in therapeutic products. Regulatory bodies mandate rigorous vigilance to detect and […]

Qinecsa Sponsors the World Drug Safety Congress Europe

We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress Europe 2024, marking our third year! EUROPE’S MOST EXCITING DRUG SAFETY & PV EVENT The World Drug Safety Congress Europe is where key communities and industries come together to discuss the latest advancements in drug safety. From exploring the use […]

Streamline AE, PQC & MI call handling operations with Reportum

Call centres are typically responsible for a high percentage of safety report entry. However, the nature of the reporting process means it is hard to control, often involving complex fixed pdf forms that can lead to incomplete data and require follow-up to achieve the desired level of data quality. Reportum® is a highly scalable, centralised […]

Standardise safety data collection with Reportum

Understanding patient safety is an essential element of Patient Support Programs. However, traditional safety reporting systems involve multi-step manual processes that often result in compliance failures and late or unreported cases. Reportum® is a highly scalable, centralised solution that assists PSP nurse and call centre reporting to ensure standardised and complete data capture across third-party […]

Simplify safety reporting on-the-go with Reportum

Safety reporting is not a core focus for field-based staff, therefore inputting of reports is often completed at a later time. This means report entry is frequently incomplete and often delayed, which puts pressure on the safety team to comply with required timelines. Reportum® offers a simple, easy-to-use interface that guides the capture of relevant, […]